Variant report
Variant | nsv875195 |
---|---|
Chromosome Location | chr2:141407101-141542081 |
allele | n/a |
Outlinks | Ensembl   UCSC |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:141402400-141408000 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
2 | chr2:141406200-141407200 | Enhancers | A549 | lung |
3 | chr2:141406200-141407600 | Enhancers | Hela-S3 | cervix |
4 | chr2:141406200-141408200 | Weak transcription | HUVEC | blood vessel |
5 | chr2:141407200-141408200 | Weak transcription | A549 | lung |
6 | chr2:141407600-141408000 | Weak transcription | Hela-S3 | cervix |
7 | chr2:141408000-141408200 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
8 | chr2:141408000-141408600 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
9 | chr2:141408000-141408600 | Enhancers | Hela-S3 | cervix |
10 | chr2:141408000-141408800 | Enhancers | Muscle Satellite Cultured Cells | -- |
11 | chr2:141408200-141408800 | Flanking Active TSS | A549 | lung |
12 | chr2:141408200-141408800 | Enhancers | HUVEC | blood vessel |
13 | chr2:141408600-141412200 | Weak transcription | Hela-S3 | cervix |
14 | chr2:141408800-141409200 | Weak transcription | HUVEC | blood vessel |
15 | chr2:141408800-141410000 | Enhancers | A549 | lung |
16 | chr2:141409200-141409400 | Enhancers | HUVEC | blood vessel |
17 | chr2:141409400-141413000 | Weak transcription | HUVEC | blood vessel |
18 | chr2:141410000-141412000 | Weak transcription | A549 | lung |
19 | chr2:141411800-141412600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
20 | chr2:141412000-141412400 | Flanking Active TSS | A549 | lung |
21 | chr2:141412000-141412600 | Enhancers | Fetal Brain Female | brain |
22 | chr2:141412200-141412400 | Enhancers | Hela-S3 | cervix |
23 | chr2:141412400-141413000 | Weak transcription | Hela-S3 | cervix |
24 | chr2:141412400-141414000 | Active TSS | A549 | lung |
25 | chr2:141413000-141413200 | Flanking Active TSS | HUVEC | blood vessel |
26 | chr2:141413000-141413800 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
27 | chr2:141413000-141413800 | Active TSS | HUES6 Cell Line | embryonic stem cell |
28 | chr2:141413000-141417400 | Enhancers | Hela-S3 | cervix |
29 | chr2:141413200-141413600 | Active TSS | HUVEC | blood vessel |
30 | chr2:141413600-141413800 | Flanking Active TSS | HUVEC | blood vessel |
31 | chr2:141413800-141417200 | Enhancers | HUVEC | blood vessel |
32 | chr2:141414000-141416400 | Enhancers | A549 | lung |
33 | chr2:141414200-141418200 | Enhancers | Pancreatic Islets | Pancreatic Islet |
34 | chr2:141415400-141415600 | Enhancers | Fetal Lung | lung |
35 | chr2:141416200-141417000 | Enhancers | Fetal Kidney | kidney |
36 | chr2:141416400-141416600 | Flanking Active TSS | A549 | lung |
37 | chr2:141416600-141416800 | Enhancers | A549 | lung |
38 | chr2:141416800-141417400 | Flanking Active TSS | A549 | lung |
39 | chr2:141417000-141420800 | Weak transcription | Fetal Kidney | kidney |
40 | chr2:141417400-141418000 | Enhancers | A549 | lung |
41 | chr2:141420400-141421200 | Enhancers | Adipose Nuclei | Adipose |
42 | chr2:141420800-141421200 | Enhancers | Fetal Kidney | kidney |
43 | chr2:141421200-141422000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
44 | chr2:141422000-141424400 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
45 | chr2:141424000-141424800 | Enhancers | Dnd41 | blood |
46 | chr2:141424000-141425800 | Enhancers | Pancreatic Islets | Pancreatic Islet |
47 | chr2:141424400-141424800 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
48 | chr2:141424400-141425200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
49 | chr2:141425800-141426400 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
50 | chr2:141426400-141426600 | Enhancers | Pancreatic Islets | Pancreatic Islet |